ClinicalTrials.gov
public full text
Public Domain
Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
Primary: To assess the safety of SL77.0499-10 10mg administered once daily for one year in patients with lower urinary tract symptoms related to BPH. Secondary: * To provide the information on the efficacy of SL77.0499-10 10mg administered once daily for one year in patients with lower urinary tract symptoms related to BPH. * To document the plasma concentration of SL77.0499-10 after repeated administration of SL77.0499-10 10mg administered once daily in patients with lower urinary tract symptoms related to BPH.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects#894530
- Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males#1072238
- Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects#897489
- Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers#1085481
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)#1114396
Record · ID 900142
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive